Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Stifel Initiates Coverage On TransMedics Group with Hold Rating, Announces Price Target of $115

Author: Benzinga Newsdesk | September 04, 2025 12:02pm

Stifel analyst Thomas Stephan initiates coverage on TransMedics Group (NASDAQ:TMDX) with a Hold rating and announces Price Target of $115.

Posted In: TMDX